Development of emulsions using modified safflower globulin shows high encapsulation efficiency for lycopene, indicating strong delivery potential.
This study investigated the synergistic effect of ultrasound in combination with pH-shifting and heating modification on the physicochemical properties, structural characteristics, and emulsifying performance of safflower seed meal globulin (SMG). Furthermore, the efficacy of the modified protein (UHA-SMG) as a natural emulsifier was evaluated for preparing lycopene (LYC)-loaded high internal phase emulsions (HIPEs). Under the suitable modification conditions (ultrasonic power: 500 W, ultrasonic time: 5 min, temperature: 70 °C, pH: 9.0), UHA-SMG exhibited obvious improved physicochemical properties, including altered micromorphology, reduced particle size and interfacial tension, as well as enhanced zeta-potential, surface hydrophobicity, wettability, and solubility. Structural characterization via far-UV circular dichroism, UV–Vis, and fluorescence spectroscopy indicated that the modification altered the secondary and tertiary structures of SMG, as evidenced by a rise in α-helical content and greater exposure of internal hydrophobic groups and aromatic amino acids to the solvent. At a concentration of 2.0% (w/v), UHA-SMG successfully stabilized oil-in-water HIPEs with an internal phase volume of 75%. These HIPEs demonstrated typical shear-thinning behavior, gel-like rheological characteristics (G’ > G’’), and excellent stability against centrifugation, heating, and long-term storage. For LYC encapsulation, the HIPEs formulated with 2.0% (w/v) UHA-SMG achieved a high encapsulation efficiency of 96.39 ± 1.34% and provided markedly enhanced stability of LYC against UV irradiation, thermal degradation, and storage compared to free LYC. In summary, the synergistic triple-modification strategy (ultrasound, heating, and pH-shifting) significantly enhanced the functionality of SMG, rendering it a promising candidate as a bio-based stabilizer for HIPEs with considerable potential in lipophilic bioactive ingredient delivery systems.
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: